Iterum Therapeutics PLC (ITRM)
1.255
0.00 (0.00%)
USD |
NASDAQ |
Jul 26, 16:00
1.29
+0.04
(+2.79%)
After-Hours: 20:00
Iterum Therapeutics Enterprise Value: 22.57M for July 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| July 25, 2024 | 22.57M |
| July 24, 2024 | 22.65M |
| July 23, 2024 | 23.23M |
| July 22, 2024 | 22.57M |
| July 19, 2024 | 22.08M |
| July 18, 2024 | 22.57M |
| July 17, 2024 | 23.23M |
| July 16, 2024 | 24.14M |
| July 15, 2024 | 28.03M |
| July 12, 2024 | 29.03M |
| July 11, 2024 | 28.45M |
| July 10, 2024 | 26.21M |
| July 09, 2024 | 24.23M |
| July 08, 2024 | 23.40M |
| July 05, 2024 | 20.92M |
| July 03, 2024 | 20.42M |
| July 02, 2024 | 19.92M |
| July 01, 2024 | 20.01M |
| June 28, 2024 | 20.83M |
| June 27, 2024 | 21.74M |
| June 26, 2024 | 22.08M |
| June 25, 2024 | 21.91M |
| June 24, 2024 | 21.25M |
| June 21, 2024 | 22.41M |
| June 20, 2024 | 20.92M |
| Date | Value |
|---|---|
| June 18, 2024 | 20.42M |
| June 17, 2024 | 20.58M |
| June 14, 2024 | 20.92M |
| June 13, 2024 | 21.25M |
| June 12, 2024 | 21.74M |
| June 11, 2024 | 21.41M |
| June 10, 2024 | 23.40M |
| June 07, 2024 | 24.72M |
| June 06, 2024 | 25.22M |
| June 05, 2024 | 26.38M |
| June 04, 2024 | 26.54M |
| June 03, 2024 | 25.55M |
| May 31, 2024 | 26.71M |
| May 30, 2024 | 23.23M |
| May 29, 2024 | 23.23M |
| May 28, 2024 | 23.73M |
| May 24, 2024 | 24.23M |
| May 23, 2024 | 24.89M |
| May 22, 2024 | 25.39M |
| May 21, 2024 | 25.22M |
| May 20, 2024 | 25.88M |
| May 17, 2024 | 25.22M |
| May 16, 2024 | 26.38M |
| May 15, 2024 | 26.54M |
| May 14, 2024 | 26.71M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-25.88M
Minimum
Sep 23 2022
394.05M
Maximum
Feb 10 2021
41.62M
Average
25.15M
Median
Dec 21 2021
Enterprise Value Benchmarks
| Alkermes PLC | 4.029B |
| Jazz Pharmaceuticals PLC | 10.80B |
| Medtronic PLC | 117.77B |
| Perrigo Co PLC | 7.241B |
| Trinity Biotech PLC | 96.16M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.101M |
| Total Expenses (Quarterly) | 6.163M |
| EPS Diluted (Quarterly) | -0.46 |
| Earnings Yield | -211.2% |
| Normalized Earnings Yield | -7912.35 |